logo
IAEA report says Iran had secret activities with undeclared nuclear material

IAEA report says Iran had secret activities with undeclared nuclear material

Yahoo2 days ago

VIENNA (Reuters) -Iran previously carried out secret nuclear activities with material not declared to the U.N. nuclear watchdog at three locations that have long been under investigation, the watchdog said in a wide-ranging, confidential report to member states seen by Reuters.
The International Atomic Energy Agency has concluded that "these three locations, and other possible related locations, were part of an undeclared structured nuclear programme carried out by Iran until the early 2000s and that some activities used undeclared nuclear material", the "comprehensive" report requested by the IAEA's Board of Governors in November said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OPEC+ Ups The Ante Via Another 411,000 Barrels Per Day Oil Output Hike
OPEC+ Ups The Ante Via Another 411,000 Barrels Per Day Oil Output Hike

Forbes

time41 minutes ago

  • Forbes

OPEC+ Ups The Ante Via Another 411,000 Barrels Per Day Oil Output Hike

The logo of the Organization of Petroleum Exporting Countries (OPEC) is seen at its headquarters in ... More Vienna, Austria. (Photo: Joe Klamar) Oil producers' group OPEC+ decided to up its production levels despite weak crude prices in what is being seen as a bid to hold on to its market share in a tough economic environment. At their meeting on Saturday, eight members of OPEC+, a select group of Russia-led oil producers and the Organization of the Petroleum Exporting Countries (OPEC) spearheaded by Saudi Arabia, opted to raise collective production levels for July by another 411,000 barrels per day. Producers Saudi Arabia, Russia, Iraq, UAE, Kuwait, Kazakhstan, Algeria, and Oman cited 'healthy market fundamentals and low oil inventories' as their reasons behind the move indicating their belief that the global oil market can absorb the additional supply. The decision over the weekend was third consecutive output hike announced by OPEC+. Earlier in May, it agreed to up oil production for a second consecutive month, raising output for June by a similar 411,000 bpd level. The June hike by OPEC+ took the total combined production increases for April, May and June to 960,000 bpd, or 44% of the 2.2 million bpd of previously agreed cuts since 2022. The latest hike implies a higher unwinding of over 1.37 million bpd (or 62%). In a statement, OPEC+ also noted: 'The gradual increases may be paused or reversed subject to evolving market conditions. This flexibility will allow the group to continue to support oil market stability.' The group is scheduled to meet on July 6 to decide on its production levels for August, the week of OPEC's International Seminar - an event it organizes every two years to draw in major industry players. Barring a considerable deteriorating in the macroeconomic climate, another production hike appears to be on the horizon next month as well. The move is a clear bid for a greater market share at the expense of non-OPEC producers, especially U.S. light sweet crude suppliers. Investment banks and other forecasters are scrambling to lower their oil price forecasts while the International Energy Agency is forecasting a market surplus. But there is another strategic reason behind the move by OPEC+ heavyweight and de facto leader Saudi Arabia - that of disciplining errant overproducing fellow members alongside non-OPEC competitors. They include the likes of Iraq and Kazakhstan, which have repeatedly exceeded their oil production quotas. For instance, the latter exceeded its March target by 422,000 bpd. As a result, squeezed profit margins beckon for the entire oil industry if prices remain low. That is the likely expectation on Wall Street courtesy of higher production from OPEC+ as well as non-OPEC producers like the U.S., Brazil, Canada and Guyana. And despite a claim by OPEC+ of falling inventories, latest data on oil storage is sending bearish market signals. According to the IEA, global inventories continue to remain elevated. In its market assessment published on May 15, it said inventories rose for a second consecutive month to 7.7 billion barrels in March. While the said figure may be below the five-year average, a change in sentiment appears to be pretty clear. For the IEA currently expects oil inventories to rise by an average of 720,000 bpd this year, and by 930,000 bpd in 2026. If this drags OPEC+ producers and their competitors toward a full-blown glut, another tussle for market share at low prices beckons.

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

Yahoo

time41 minutes ago

  • Yahoo

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics. This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies. Under the agreement, ASP Isotopes will leverage its proprietary Quantum Enrichment technology to provide Isotopia with enriched Gd-160, a stable isotope essential for manufacturing Tb-161. The collaboration combines ASP Isotopes' expertise in large-scale isotope enrichment—previously demonstrated through its production of Ytterbium-176 (Yb-176)—with Isotopia's proven capabilities in commercial-scale medical isotope production. Isotopia has consistently manufactured Lutetium-177 (Lu-177) and maintained weekly Tb-161 production for its clinical trials over the past two years. Paul Mann, CEO of ASP Isotopes, emphasized the agreement's significance: "By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry's growing demand for stable isotopes. This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms." Dr. Eli Shalom, CEO of Isotopia, highlighted Tb-161's therapeutic advantages: "Tb-161's dual mechanism of action, including Auger electron emissions, enables precise targeting of micro-metastases while minimizing damage to healthy tissues. This partnership ensures a reliable Gd-160 supply chain, allowing us to scale production and advance our Tb-161-labeled drug candidates toward commercialization. We produce in our site in Israel and shortly the production will start in our second site in Indianapolis in the US." Tb-161's Auger electrons induce double-strand DNA breaks in cancer cells, offering potential advantages over Lu-177 and alpha-emitting isotopes. This precision aligns with the oncology field's shift toward targeted radiotherapeutics, which improve efficacy and reduce side effects. The agreement comes as global interest in radiopharmaceuticals surges, driven by their ability to deliver localized radiation therapy via tumor-seeking molecules. About ASP Isotopes Inc. ASP Isotopes Inc. specializes in advanced isotope separation technologies, including its proprietary Aerodynamic Separation Process and Quantum Enrichment, which produce stable isotopes without radioactive waste. The company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company has isotope enrichment facilities in Pretoria, South Africa. For more information, please visit About Isotopia Molecular Imaging Ltd. Isotopia is a global leader in medical isotope production, with facilities in Israel, Europe, and the U.S. Its integrated platform includes cyclotrons, Lu-177 and Tb-161 production sites, and sterile manufacturing capabilities. The company collaborates with researchers and clinicians to develop novel radiopharmaceuticals for diagnostics and targeted therapy. This partnership positions both companies at the forefront of the radiopharmaceutical revolution, with the potential to expand treatment options for cancer patients worldwide. Contact: eshalom@ SOURCE Isotopia

Oil Rises Amid Geopolitical Tensions
Oil Rises Amid Geopolitical Tensions

Wall Street Journal

timean hour ago

  • Wall Street Journal

Oil Rises Amid Geopolitical Tensions

2356 GMT — Oil rises in the early Asian session amid geopolitical tensions. Ukraine launched drone attacks on four military airports inside Russia, destroying more than 40 warplanes. The International Atomic Energy Agency said in a confidential report viewed by The Wall Street Journal that Iran has continued to produce highly enriched uranium over the past three months despite talks between Washington and Tehran on a new nuclear deal. 'On geopolitics, risks continue to provide a bullish support to oil prices against an otherwise softening physical backdrop,' Citi Research's strategist Francesco Martoccia says in a note. Front-month WTI crude oil futures are up 1.9% at $61.96/bbl; front-month Brent crude oil futures are 1.7% higher at $63.83/bbl. (

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store